- increased bone mineral density / IMPC
- decreased body weight / IMPC
- abnormal lens morphology / IMPC
- cataract / IMPC
- increased circulating triglyceride level / IMPC
- increased circulating free fatty acids level / IMPC
- increased circulating glycerol level / IMPC
- abnormal behavior / IMPC
- decreased circulating creatinine level / IMPC
- increased circulating magnesium level / IMPC
C57BL/6NTac-Trmt10atm1a(EUCOMM)Wtsi/WtsiOulu
Status | Available to order |
EMMA ID | EM:05441 |
International strain name | C57BL/6NTac-Trmt10atm1a(EUCOMM)Wtsi/WtsiOulu |
Alternative name | EPD0140_1_C09 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Trmt10atm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Trmt10a |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0140_1_C09. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References |
|
Information from EMMA
Archiving centre | University of Oulu, Oulu, Finland |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome / Orphanet_391408
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- abnormal lens morphology / IMPC
- increased circulating magnesium level / IMPC
- decreased circulating creatinine level / IMPC
- increased circulating glycerol level / IMPC
- decreased body weight / IMPC
- cataract / IMPC
- abnormal behavior / IMPC
- increased circulating free fatty acids level / IMPC
- increased circulating triglyceride level / IMPC
- increased bone mineral density / IMPC
MGI phenotypes (allele matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- decreased body weight / MGI
- abnormal lens morphology / MGI
- cataract / MGI
- increased circulating free fatty acid level / MGI
- decreased circulating alanine transaminase level / MGI
- increased circulating glycerol level / MGI
- decreased circulating cholesterol level / MGI
- decreased circulating aspartate transaminase level / MGI
- increased sacral vertebrae number / MGI
- increased circulating magnesium level / MGI
MGI phenotypes (gene matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- decreased body weight / MGI
- abnormal lens morphology / MGI
- cataract / MGI
- increased circulating free fatty acid level / MGI
- decreased circulating alanine transaminase level / MGI
- increased circulating glycerol level / MGI
- decreased circulating cholesterol level / MGI
- decreased circulating aspartate transaminase level / MGI
- increased circulating magnesium level / MGI
- increased sacral vertebrae number / MGI
Literature references
- Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).